Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2011 (2011), Article ID 591793, 8 pages
http://dx.doi.org/10.4061/2011/591793
Research Article

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens

1Bone Health and Osteoporosis Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
2NorthShore University HealthSystem, Evanston, IL 60201, USA
3Kovler Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

Received 11 February 2011; Revised 26 May 2011; Accepted 14 June 2011

Academic Editor: Pawel Szulc

Copyright © 2011 B. J. Edwards et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Cohen and E. Shane, “Osteoporosis after solid organ and bone marrow transplantation,” Osteoporosis International, vol. 14, no. 8, pp. 617–630, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Cohen, P. Sambrook, and E. Shane, “Management of bone loss after organ transplantation,” Journal of Bone and Mineral Research, vol. 19, no. 12, pp. 1919–1932, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. N. M. Maalouf and E. Shane, “Clinical review: osteoporosis after solid organ transplantation,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 2456–2465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Martin, Z. Al-Aly, and E. A. Gonzalez, “Renal osteodystrophy,” in Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism, M. Favus, Ed., pp. 359–366, Philadelphia, Pa, USA, American Society of Bone and Mineral Research, 2006. View at Google Scholar
  5. E. Shane, M. Rivas, R. B. Staron et al., “Fracture after cardiac transplantation: a prospective longitudinal study,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 5, pp. 1740–1746, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Sprague and M. A. Josephson, “Bone disease after kidney transplantation,” Seminars in Nephrology, vol. 24, no. 1, pp. 82–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. D. E. Hricik, M. A. O'Toole, J. A. Schulak, and J. Herson, “Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis,” Journal of the American Society of Nephrology, vol. 4, no. 6, pp. 1300–1305, 1993. View at Google Scholar · View at Scopus
  8. EBPG Expert Group on Renal Transplantation, “European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.3.1 Long-term immunosuppression. Late steroid or cyclosporine withdrawal,” Nephrology, Dialysis, Transplantation, vol. 17, supplement 4, pp. 19–20, 2002. View at Google Scholar
  9. R. Ramsey-Goldman, J. E. Dunn, D. D. Dunlop et al., “Increased risk of fracture in patients receiving solid organ transplants,” Journal of Bone and Mineral Research, vol. 14, no. 3, pp. 456–463, 1999. View at Google Scholar · View at Scopus
  10. M. M. J. Guichelaar, J. Schmoll, M. Malinchoc, and J. E. Hay, “Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors,” Hepatology, vol. 46, no. 4, pp. 1198–1207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Collier, “Bone disorders in chronic liver disease,” Hepatology, vol. 46, no. 4, pp. 1271–1278, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. E. J. Carey, V. Balan, W. K. Kremers, and J. E. Hay, “Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem,” Liver Transplantation, vol. 9, no. 11, pp. 1166–1173, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. V. Torregrosa, J. M. Campistol, M. Montesinos et al., “Factors involved in the loss of bone mineral density after renal transplantation,” Transplantation Proceedings, vol. 27, no. 4, pp. 2224–2225, 1995. View at Google Scholar · View at Scopus
  14. H. D. McIntyre, B. Menzies, R. Rigby, D. A. Perry-Keene, C. M. Hawley, and I. R. Hardie, “Long-term bone loss after renal transplantation: comparison of immmunosuppressive regimens,” Clinical Transplantation, vol. 9, no. 1, pp. 20–24, 1995. View at Google Scholar · View at Scopus
  15. A. M. Cueto-Manzano, S. Konel, V. Crowley et al., “Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients,” Transplantation, vol. 75, no. 12, pp. 2053–2058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Angeli, G. Guglielmi, A. Dovio et al., “High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study,” Bone, vol. 39, no. 2, pp. 253–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Bozkaya, A. Nart, A. Uslu et al., “Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients,” Transplantation Proceedings, vol. 40, no. 1, pp. 151–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Giannini, M. Nobile, and L. Sartori, “Organ transplantation and glucocorticoid-induced osteoporosis,” Frontiers of Hormone Research, vol. 30, pp. 94–106, 2002. View at Google Scholar · View at Scopus
  19. M. Y. Chiu, S. M. Sprague, D. S. Bruce, E. Steve Woodle, J. R. Thistlethwaite, and M. A. Josephson, “Analysis of fracture prevalence in kidney-pancreas allograft recipients,” Journal of the American Society of Nephrology, vol. 9, no. 4, pp. 677–683, 1998. View at Google Scholar · View at Scopus
  20. A. M. Alem, D. J. Sherrard, D. L. Gillen et al., “Increased risk of hip fracture among patients with end-stage renal disease,” Kidney International, vol. 58, no. 1, pp. 396–399, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. S. D. Roe, C. J. Porter, I. M. Godber, D. J. Hosking, and M. J. Cassidy, “Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism,” Osteoporosis International, vol. 16, no. 2, pp. 142–148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Ninkovic, S. J. Skingle, P. W. P. Bearcroft, N. Bishop, G. J. M. Alexander, and J. E. Compston, “Incidence of vertebral fractures in the first three months after orthotopic liver transplantation,” European Journal of Gastroenterology and Hepatology, vol. 12, no. 8, pp. 931–935, 2000. View at Google Scholar · View at Scopus
  23. A. H. Lee, R. L. Mull, G. F. Keenan et al., “Osteoporosis and bone morbidity in cardiac transplant recipients,” American Journal of Medicine, vol. 96, no. 1, pp. 35–41, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Sprague, V. Belozeroff, M. D. Danese, L. P. Martin, and K. Olgaard, “Abnormal bone and mineral metabolism in kidney transplant patients—a review,” American Journal of Nephrology, vol. 28, no. 2, pp. 246–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Saller, S. Maggi, G. Romanato, P. Tonin, and G. Crepaldi, “Diabetes and osteoporosis,” Aging: Clinical and Experimental Research, vol. 20, no. 4, pp. 280–289, 2008. View at Google Scholar · View at Scopus
  26. S. Epstein and D. LeRoith, “Diabetes and fragility fractures—a burgeoning epidemic?” Bone, vol. 43, no. 1, pp. 3–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. L. J. Melton III, C. L. Leibson, S. J. Achenbach, T. M. Therneau, and S. Khosla, “Fracture risk in type 2 diabetes: update of a population-based study,” Journal of Bone and Mineral Research, vol. 23, no. 8, pp. 1334–1342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Välimäki, K. Kinnunen, L. Volin et al., “A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin,” Bone Marrow Transplantation, vol. 23, no. 4, pp. 355–361, 1999. View at Google Scholar
  29. J. S. Tenover, “Declining testicular function in aging men,” International Journal of Impotence Research, vol. 15, no. 4, pp. S3–S8, 2003. View at Google Scholar · View at Scopus
  30. N. Napoli, R. Faccio, V. Shrestha, S. Bucchieri, G. B. Rini, and R. Armamento-Villareal, “Estrogen metabolism modulates bone density in men,” Calcified Tissue International, vol. 80, no. 4, pp. 227–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Weiss, R. Yogev, and E. Dolev, “Occupational sitting and low hip mineral density,” Calcified Tissue International, vol. 62, no. 1, pp. 47–50, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. F. Smets, J. W. de Fijter, J. Ringers, H. H. Lemkes, and N. A. Hamdy, “Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidney transplantation,” Kidney international, vol. 66, no. 5, pp. 2070–2076, 2004. View at Google Scholar · View at Scopus
  33. Y. F. C. Smets, J. W. Van Der Piji, J. W. De Fijter, J. Ringers, H. H. P. J. Lemkes, and N. A. T. Hamdy, “Low bone mass and high incidence of fractures after successful simultaneous pancreas-kidney transplantation,” Nephrology Dialysis Transplantation, vol. 13, no. 5, pp. 1250–1255, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. D. S. Bruce, K. A. Newell, M. A. Josephson et al., “Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year,” Transplantation, vol. 62, no. 4, pp. 451–456, 1996. View at Google Scholar · View at Scopus
  35. M. Janghorbani, R. M. Van Dam, W. C. Willett, and F. B. Hu, “Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture,” American Journal of Epidemiology, vol. 166, no. 5, pp. 495–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Rakel, O. Sheehy, E. Rahme, and J. LeLorier, “Does diabetes increase the risk for fractures after solid organ transplantation? A nested case-control study,” Journal of Bone and Mineral Research, vol. 22, no. 12, pp. 1878–1884, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Leidig-Bruckner, S. Hosch, P. Dodidou et al., “Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study,” Lancet, vol. 357, no. 9253, pp. 342–347, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Epstein, “Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton,” Journal of Bone and Mineral Research, vol. 11, no. 1, pp. 1–7, 1996. View at Google Scholar · View at Scopus
  39. S. Kirino, J. Fukunaga, S. Ikegami et al., “Regulation of bone metabolism in immunosuppressant (FK506)-treated rats,” Journal of Bone and Mineral Metabolism, vol. 22, no. 6, pp. 554–560, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Cvetkovic, G. N. Mann, D. F. Romero et al., “The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo,” Transplantation, vol. 57, no. 8, pp. 1231–1237, 1994. View at Google Scholar · View at Scopus
  41. E. M. Awumey, B. S. Moonga, B. R. Sodam et al., “Molecular and functional evidence for calcineurin-A α and β isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption,” Biochemical and Biophysical Research Communications, vol. 254, no. 1, pp. 248–252, 1999. View at Publisher · View at Google Scholar
  42. L. Sun, L. L. Zhu, N. Zaidi et al., “Cellular and molecular consequences of calcineurin Aα gene deletion,” Annals of the New York Academy of Sciences, vol. 1116, pp. 216–226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Inoue, I. Kawamura, M. Matsuo et al., “Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats,” Transplantation, vol. 70, no. 5, pp. 774–779, 2000. View at Google Scholar · View at Scopus
  44. A. Monegal, M. Navasa, N. Guañabens et al., “Bone mass and mineral metabolism in liver transplant patients treated with FK506 or Cyclosporine A,” Calcified Tissue International, vol. 68, no. 2, pp. 83–86, 2001. View at Google Scholar
  45. E. Goffin, J. P. Devogelaer, A. Lalaoui et al., “Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation,” Transplant International, vol. 15, no. 2-3, pp. 73–80, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. I. R. Dissanayake and S. Epstein, “The fate of bone after renal transplantation,” Current Opinion in Nephrology and Hypertension, vol. 7, no. 4, pp. 389–395, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. J. M. Campistol, D. W. Holt, S. Epstein, M. Gioud-Paquet, K. Rutault, and J. T. Burke, “Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus,” Transplant International, vol. 18, no. 9, pp. 1028–1035, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Pichette, A. Bonnardeaux, L. Prudhomme, M. Gagné, J. Cardinal, and D. Ouimet, “Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study,” American Journal of Kidney Diseases, vol. 28, no. 1, pp. 105–114, 1996. View at Google Scholar · View at Scopus
  49. L. M. Vautour, L. J. Melton, B. L. Clarke, S. J. Achenbach, A. L. Oberg, and J. T. McCarthy, “Long-term fracture risk following renal transplantation: a population-based study,” Osteoporosis International, vol. 15, no. 2, pp. 160–167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Monegal, M. Navasa, N. Guañabens et al., “Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation,” Calcified Tissue International, vol. 60, no. 2, pp. 148–154, 1997. View at Publisher · View at Google Scholar · View at Scopus